Rheumatoid Arthritis
Overview
Diagnosis
Therapy/Surgery
- JAK Inhibitors - HSS Study Reveals How New Drugs Help Stop Inflammation
- In RA patients unresponsive to several DMARDs but who are PPD+ although the chest X-ray is negative, how long should INH prophylaxis be maintained before initiating an anti-TNF agent? Is anakinra safe to use in patients with a positive PPD?
- Would a history of optic neuritis be considered a contraindication for TNF-alpha inhibitor therapy? In the few cases of MS-type symptoms in patients on these therapies, have the symptoms reversed when the medications were discontinued?
- Rheumatoid Arthritis - Combination Therapy
- RA Therapeutics - Board Review
- The History, Basic Science and Biology of TNF
- Our Amazing Progress - and More Within Rheumatology's Grasp
- Lower the Thermostat - the Heat is Too High: Winning the Battle and the War
- A Call to Arms: Treat Rheumatologic Disorders Early and Effectively with Disease-modifying Therapy
- Gene Therapy in Rheumatoid Arthritis
- Pulmonary Nodules in an Infliximab-Treated Rheumatoid Arthritis Patien
- Combination Therapy in Rheumatoid Arthritis
- Which treatments worsen rheumatoid nodules, and which makes them resolve?
- Can tight control of early RA with a DAS target yield significantly better outcomes?
- Quality of Life Benefits for TNF-Blockers vs. DMARDs
- How do patients respond to support groups such as those at HSS for lupus, rheumatoid arthritis, and myositis? Do patients with mild disease get upset seeing the severe cases?
- Disparities in Treatment: A Decision Sciences Perspective
Complications & Secondary Illness
- CPC: Cyclophosphamide Responsive Interstitial Lung Disease in "Overlap Syndrome"
- Is methotrexate contraindicated in rheumatoid arthritis patients who have evidence of hepatitis B or C?What options are available for such patients if biologic agents are financially out of reach?
- Can TNF inhibitors be used in HIV-positive patients?
- In patients with rheumatoid arthritis who have evidence of hepatitis B or C infection, can TNF-a antagonists or IL-1 antagonists be safely used?
- What has been the experience with anti-TNF agents during pregnancy? Should they be discontinued prior to pregnancy and, if so, how far ahead of a planned pregnancy?
- Rheumatoid Arthritis: Systemic Disorder with Major Collateral Damage - Board Review
Research
- Incorporating the Patient Perspective: Developing a Patient-Focused Evaluation for an Early RA Support and Education Program
- New Discovery: A Pathway That Can Stop Inflammation in Rheumatoid Arthritis
- New Biomarker May Show Whether Patients Can Benefit From Costly Biologic Drugs
- The Clinical and Immunological Personality of Rheumatoid Arthritis: An Interview with Experts
- HSS Manual Ch. 5 - Immunogenetic Aspects Of Rheumatic Diseases
- Complementary and Alternative Medicine in Rheumatoid Arthritis: No Longer the Last Resort!
- Is There a Role for NFAT Inhibitors in the Prevention of Bone Destruction?
- Disparities in Treatment: A Decision Sciences Perspective
- Imaging of Juvenile Rheumatoid Arthritis
Clinical Trials
- Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry38880
- Quantitative Assessment of the Synovial Vascularity in Early Inflammatory Arthritis
- Database of the Gosden Robinson Early Arthritis Center (EAC): Analysis of Types of Patients Recruited to an Urban EAC
- CORRONA Data Collection Program
Related Conditions/Issues
- Patient Self-Assessments May Reliably Identify Disease Flare in Early Rheumatoid Arthritis
- Will Talking about It Make It Worse? Engaging Patients’ Families around the Impact of Illness
- Focusing on Doctor-Patient Communication with Older Adults
- Common Pulmonary Problems in Rheumatology
- HSS Manual Ch. 4 - Rheumatologic Laboratory Tests
- Ethical Issues in Rheumatology
- Ethics in Rheumatology
- Justice and Health Care in Rheumatic Diseases
- Vaccinations and Rheumatic Disease
Development of Condition
Treatments
- Bextra® Withdrawal from the Market - HSS Physicians Reflect on Options for Patients in Pain
- Two New Biologic Agents for Rheumatoid Arthritis: Rituximab (Rituxan) and Abatacept (Orencia)
- CPC: Pulmonary Nodules in an Infliximab-Treated Rheumatoid Arthritis Patient
- Perioperative Management of Medications Used in the Treatment of Rheumatoid Arthritis
- Rheumatoid Arthritis - Combination Therapy
- Combination Therapy for Rheumatoid Arthritis in the Era of Biologicals
- RA Therapeutics - Board Review
- Gene Therapy in Rheumatoid Arthritis
- Combination Therapy in Rheumatoid Arthritis
- Medical Management of Arthritis: Early Diagnosis and Current Therapies
- Total Ankle Replacement in Patients with Rheumatoid Arthritis
- Rheumatoid Arthritis: Systemic Disorder with Major Collateral Damage - Board Review
- Complementary and Alternative Medicine in Rheumatoid Arthritis: No Longer the Last Resort!
- Contact HSS
- Give to HSS
- Maps and Directions
- Notice of Privacy Practices
- Terms of Use
- Joint Commission Notice
- HSS Staff Login
© Hospital for Special Surgery. 535 East 70th Street, New York, NY 10021
